Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Published:2017-02 Issue:4 Volume:168 Page:707-723
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Sharma Padmanee,Hu-Lieskovan Siwen,Wargo Jennifer A.,Ribas Antoni

Funder

NIH/NCI

Cancer Prevention Research in Texas

Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Research

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference185 articles.

1. Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors;Akbay;Cancer Discov.,2013

2. Anti-CD73 therapy impairs tumor angiogenesis;Allard;Int. J. Cancer,2014

3. Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation;Anderson;Immunity,2016

4. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma;Ansell;N. Engl. J. Med.,2015

5. Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies;Beatty;Cancer Immunol. Res.,2014

Cited by 3773 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Pembrolizumab Monotherapy or Combined Therapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Current Gene Therapy;2025-02

2. A carrier-free nanovaccine combined with cancer immunotherapy overcomes gemcitabine resistance;Biomaterials;2025-02

3. Bioactive nanocomposite hydrogel enhances postoperative immunotherapy and bone reconstruction for osteosarcoma treatment;Biomaterials;2025-01

4. References;The Evolution of Immunotherapy Against Tumors;2025

5. Immunotherapy for breast cancer: New strategies to enhance the patient selection and overcome therapeutic resistance;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3